{'fraction_non_alphanumeric': 0.03125, 'fraction_numerical': 0.009375, 'mean_word_length': 5.104761904761904, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris

We report a case of psoriasis vulgaris in which chronic inflammatory demyelinating polyneuropathy (CIDP) developed during adalimumab treatment. A 42-year-old Japanese man with a history of juvenile-onset psoriasis, who had been treated with topical vitamin D analogues and corticosteroids for a long time, as well as oral cyclosporine for the last one and a half years, was administered adalimumab with a regular dose (initial dose of 80 mg, followed by 40 mg, twice a week). Seven months later, due [...]